Apigenin,
does it really help with Sleep, relaxation, and anxiety relief?
research showsNo human sleep trial of isolated apigenin was identified. Human studies used multi-constituent chamomile extracts, and efficacy of a chamomile intervention cannot be attributed to isolated apigenin tablets. The verdict remains unclassified.
ads claimGABA-A binding, a natural sleeping pill, podcast sleep stacks, and 50 mg before bed convert mechanism and popularity into claims of clinical efficacy. Receptor binding is not the same as improved human sleep.
Useful facts when choosing a product
- Fifty-milligram capsules are distributed through Korean online stores and cross-border shopping.
- A marketed instruction of 50 mg before bed is not an efficacy dose established by clinical trials.
- Apigenin exposure and co-constituents in chamomile extracts differ from an isolated 50 mg tablet.
- Long-term human safety and interaction data with sleep medicines are insufficient; pregnancy, lactation, sedatives, and anticoagulants warrant professional review.
What the research actually shows
Viola 1995 and related work concern receptor binding and mouse behavior. Human sleep evidence summarized by Kramer 2024 tested apigenin-containing chamomile extract rather than isolated apigenin. Effects of the multi-constituent chamomile intervention were therefore not extrapolated to an isolated apigenin supplement.
Why this is classified as ?
There is no human sleep trial of isolated apigenin, and multi-constituent chamomile is not ingredient-equivalent, so the verdict remains unclassified without a score.
Counterpoint. The question mark does not reject preclinical plausibility; it means human data are absent for the consumer sleep and anxiety claims.
Rejudgment record. Reassessment (cross-check reflected) — No human sleep trial of isolated apigenin exists, and multi-constituent chamomile interventions are not equivalent to isolated apigenin
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Viola et al. 1995 | Receptor-binding and mouse behavioral preclinical study | Unverified | Benzodiazepine-receptor binding and elevated plus maze | An anxiety-like behavior signal in mice, not a human sleep or anxiety outcome. | Mechanistic support | |
| Kramer & Johnson 2024 | Narrative review of sleep and aging | Authors affiliated with Tally Health | Sleep mechanisms, animal behavior, and scope of human evidence | Explicitly states that human studies of apigenin alone are needed. | Confirms evidence gap |
Receipt — 3 References
All 3 cited sources were verified for existence at the original page (as of 2026-07-17).
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-17 · Corrections: none
Cite this verdict
[Chamgap] Apigenin x sleep, relaxation, and anxiety relief — Evidence Grade ?. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/sleep/apigenin-sleep-relaxation-anxiety/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.